1. Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. (November 2020) Authors: Robinson, Philip C; Richards, Duncan; Tanner, Helen L; Feldmann, Marc Journal: Lancet Issue: Volume 2:Number 11(2020) Page Start: e653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFκB in tumour necrosis factor production. (1st November 2000) Authors: Foxwell, Brian M J; Bondeson, Jan; Brennan, Fionula; Feldmann, Marc Journal: Annals of the rheumatic diseases Issue: Volume 59(2000)Supplement 1 Page Start: i54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-TNF therapy: past, present and future. (19th November 2014) Authors: Monaco, Claudia; Nanchahal, Jagdeep; Taylor, Peter; Feldmann, Marc Journal: International immunology Issue: Volume 27:Number 1(2015:Jan.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial. (June 2022) Authors: Nanchahal, Jagdeep; Ball, Catherine; Rombach, Ines; Williams, Lynn; Kenealy, Nicola; Dakin, Helen; O'Connor, Heather; Davidson, Dominique; Werker, Paul; Dutton, Susan J; Feldmann, Marc; Lamb, Sarah E Journal: Lancet Issue: Volume 4:Number 6(2022) Page Start: e407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Balance between activating NKG2D, DNAM‐1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts. Issue 4 (August 2014) Authors: Nielsen, Natasja; Pascal, Veronique; Fasth, Andreas E. R.; Sundström, Yvonne; Galsgaard, Elisabeth D.; Ahern, David; Andersen, Martin; Baslund, Bo; Bartels, Else M.; Bliddal, Henning; Feldmann, Marc; Malmström, Vivianne; Berg, Louise; Spee, Pieter; Söderström, Kalle Journal: Immunology Issue: Volume 142:Issue 4(2014:Aug.) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor α. (1st November 2000) Authors: Williams, Richard O; Feldmann, Marc; Maini, Ravinder N Journal: Annals of the rheumatic diseases Issue: Volume 59(2000)Supplement 1 Page Start: i75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Collagen VI as a driver and disease biomarker in human fibrosis. (14th June 2021) Authors: Williams, Lynn; Layton, Thomas; Yang, Nan; Feldmann, Marc; Nanchahal, Jagdeep Journal: FEBS journal Issue: Volume 289:Number 13(2022) Page Start: 3603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue. (12th October 2007) Authors: Sacre, Sandra M; Drexler, Stefan K; Andreakos, Evangelos; Feldmann, Marc; Brennan, Fionula M; Foxwell, Brian M J Journal: Annals of the rheumatic diseases Issue: Volume 66(2007)Supplement 3 Page Start: iii81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Future prospects for anti-cytokine treatment. (1st November 2000) Authors: Feldmann, Marc; Miotla, Jadwiga; Paleolog, Ewa; Williams, Richard; Malfait, Anne-Marie; Taylor, Peter; Brennan, Fionula M; Maini, Ravinder N Journal: Annals of the rheumatic diseases Issue: Volume 59(2000)Supplement 1 Page Start: i119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Host-targeting oral antiviral drugs to prevent pandemics. Issue 10333 (9th April 2022) Authors: Dwek, Raymond A; Bell, John I; Feldmann, Marc; Zitzmann, Nicole Journal: Lancet Issue: Volume 399:Issue 10333(2022) Page Start: 1381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗